| 000 | 01801 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517135020.0 | ||
| 264 | 0 | _c20180305 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a2047-4881 | ||
| 024 | 7 |
_a10.1177/2047487317690458 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFernandes-Silva, Miguel M | |
| 245 | 0 | 0 |
_aInflammatory biomarkers and effect of exercise on functional capacity in patients with heart failure: Insights from a randomized clinical trial. _h[electronic resource] |
| 260 |
_bEuropean journal of preventive cardiology _c05 2017 |
||
| 300 |
_a808-817 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aBlood Proteins |
| 650 | 0 | 4 | _aBrazil |
| 650 | 0 | 4 | _aExercise Test |
| 650 | 0 | 4 | _aExercise Therapy |
| 650 | 0 | 4 | _aExercise Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFibrosis |
| 650 | 0 | 4 |
_aGalectin 3 _xblood |
| 650 | 0 | 4 | _aGalectins |
| 650 | 0 | 4 |
_aHeart Failure _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xblood |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOxygen Consumption |
| 650 | 0 | 4 | _aRecovery of Function |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
| 700 | 1 | _aGuimarães, Guilherme V | |
| 700 | 1 | _aRigaud, Vagner Oc | |
| 700 | 1 | _aLofrano-Alves, Marco S | |
| 700 | 1 | _aCastro, Rafael E | |
| 700 | 1 | _ade Barros Cruz, Lais G | |
| 700 | 1 | _aBocchi, Edimar A | |
| 700 | 1 | _aBacal, Fernando | |
| 773 | 0 |
_tEuropean journal of preventive cardiology _gvol. 24 _gno. 8 _gp. 808-817 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/2047487317690458 _zAvailable from publisher's website |
| 999 |
_c26829803 _d26829803 |
||